- Home
- TECX vs IIF Comparison
TECX vs IIF Comparison
Compare TECX & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- IIF
- Stock Information
- Founded
- TECX 2019
- IIF 1993
- Country
- TECX United States
- IIF United States
- Employees
- TECX N/A
- IIF N/A
- Industry
- TECX
- IIF Trusts Except Educational Religious and Charitable
- Sector
- TECX
- IIF Finance
- Exchange
- TECX Nasdaq
- IIF Nasdaq
- Market Cap
- TECX 334.4M
- IIF 250.6M
- IPO Year
- TECX 2018
- IIF N/A
- Fundamental
- Price
- TECX $19.91
- IIF $28.19
- Analyst Decision
- TECX Buy
- IIF
- Analyst Count
- TECX 6
- IIF 0
- Target Price
- TECX $78.67
- IIF N/A
- AVG Volume (30 Days)
- TECX 244.3K
- IIF 45.4K
- Earning Date
- TECX 08-13-2025
- IIF 01-01-0001
- Dividend Yield
- TECX N/A
- IIF 13.94%
- EPS Growth
- TECX N/A
- IIF N/A
- EPS
- TECX N/A
- IIF N/A
- Revenue
- TECX N/A
- IIF N/A
- Revenue This Year
- TECX N/A
- IIF N/A
- Revenue Next Year
- TECX N/A
- IIF N/A
- P/E Ratio
- TECX N/A
- IIF N/A
- Revenue Growth
- TECX N/A
- IIF N/A
- 52 Week Low
- TECX $13.70
- IIF $18.95
- 52 Week High
- TECX $61.07
- IIF $24.41
- Technical
- Relative Strength Index (RSI)
- TECX 43.97
- IIF 65.80
- Support Level
- TECX $17.97
- IIF $26.96
- Resistance Level
- TECX $20.75
- IIF $28.37
- Average True Range (ATR)
- TECX 1.40
- IIF 0.28
- MACD
- TECX -0.36
- IIF 0.05
- Stochastic Oscillator
- TECX 26.93
- IIF 87.23
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.